Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001156039-23-000024
Filing Date
2023-03-03
Accepted
2023-03-03 16:13:15
Documents
1
Period of Report
2023-03-01

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_167787796641640.html 4  
1 FORM 4 wf-form4_167787796641640.xml 4 10954
  Complete submission text file 0001156039-23-000024.txt   12568
Mailing Address 220 VIRGINIA AVENUE INDIANAPOLIS IN 46204
Business Address 220 VIRGINIA AVENUE INDIANAPOLIS IN 46204 8003311476
Elevance Health, Inc. (Issuer) CIK: 0001156039 (see all company filings)

EIN.: 352145715 | State of Incorp.: IN | Fiscal Year End: 1231
SIC: 6324 Hospital & Medical Service Plans

Mailing Address GENZYME CORP. 500 KENDALL STREET CAMBRIDGE MA 02142
Business Address
BOUDREAUX GAIL (Reporting) CIK: 0001287920 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-16751 | Film No.: 23704088